Overall, even though further studies are needed to precisely unveil the role and significance of survivin in MPNST, its large expression in pediatric cases underscores a potential role as target of therapeutic interventions, as reported preclinically for MPNST themselves or other malignancies [12], [39]. This evidence concerns the gene BIRC5 and malignant peripheral nerve sheath tumor.